So much has been learned about the need to decentralize clinical trials during COVID, our panelists will discuss the overall landscape and considerations involved, including:

Join us for the virtual panel to hear:

• Examples of how to conduct a decentralized trial
• Regulatory considerations and current FDA guidelines
• The expanded role of patients when trial are decentralized